$NBIX...publication of INGREZZA PhIII data in the American Journal of Psychiatry ahead of April 11 PDUFA, good press leading up to FDA decision. https://www.streetinsider.com/Corporate+News/Neurocrine+(NBIX)+Says+Kinect+3+Phase+III+Study+of+INGREZZA+to+Treat+TD+Published+by+American+Journal+of+Psychiatry/12690413.html Neurocrine (NBIX) Says Kinect 3 Phase III Study of INGREZZA to Treat TD Published by American Journal of Psychiatry